D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLCby krapalmJune 1, 2026PR Newswire
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interviewby krapalmJune 1, 2026PR Newswire
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCOby krapalmJune 1, 2026PR Newswire
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLCby krapalmJune 1, 2026PR Newswire
2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancerby krapalmJune 1, 2026PR Newswire
New Taipei City Showcases Smart Manufacturing Strength at AUTOMATE 2026by krapalmJune 1, 2026PR Newswire
Carbice and Noctua Partner to Bring Advanced Thermal Pad Technology to DIY PC Buildersby krapalmJune 1, 2026PR Newswire
Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment’s Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczemaby krapalmJune 1, 2026PR Newswire
Long-term Follow-up Results of CARsgen’s Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meetingby krapalmJune 1, 2026PR Newswire
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Conceptby krapalmJune 1, 2026PR Newswire
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026by krapalmMay 31, 2026PR Newswire
Relief as Firmable locates 15,000 accounting decision-makers reported missing at leading global B2B data providerby krapalmMay 31, 2026PR Newswire
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Sessionby krapalmMay 31, 2026PR Newswire
Meta ทุ่มพัฒนา AI Wearables ใหม่ เตรียมเปิดตัวจี้อัจฉริยะและแว่นตาหลายรุ่นby krapalmMay 31, 2026May 31, 2026Tech
AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Techby krapalmMay 31, 2026PR Newswire
Xiaomi 17T เตรียมเปิดตัว 4 มิถุนายนนี้ พร้อมเผยสเปกกล้อง Leica และชิป Dimensity 8500 Ultraby krapalmMay 31, 2026May 31, 2026Tech
